Olmesartan Treatment of Insufficiently Controlled Hypertension in the Morning

Olmesartan Treatment of Insufficiently Controlled Hypertension in the Morning - OICHI Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007478

Enrollment

100

Registered

2012-04-01

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

olmesartan plus azelnidipine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with hypertension that are insufficiently treated with medication except olmesartan

Exclusion criteria

Exclusion criteria: pregnant women patients that are treated with azole antifungal drug patients that are recognized as inappropriate for study

Design outcomes

Primary

Measure	Time frame
Home blood pressure, Heart rate	—

Secondary

Measure	Time frame
Hospital blood pressure, Heart rate, Urine K excretion, Urine Na excretion, Urine Cl excretion, Urine albumin, Plasma renin activity	—

Countries

Japan

Contacts

Public ContactMasanori Kawasaki

Gifu University Graduate School of Medicine Department of Cardiology

mkawa@gifu-u.ac.jp058-230-6523

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026